Litcius/Paper detail

Isocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosis

Derek Dang, Akash Deogharkar, John McKolay, Kyle Smith, Pooja Panwalkar, Simon Hoffman, Wentao Tian, Sunjong Ji, Ana Paula Azambujá, Siva Kumar Natarajan, Joanna Lum, Jill Bayliss, Katie Manzeck, Stefan R. Sweha, Erin Hamanishi, Matthew Pun, Diya Patel, Sagar Rau, Olamide Animasahun, Abhinav Achreja, Martin P. Ogrodzinski, Jutta Diessl, Jennifer Cotter, Debra Hawes, Fusheng Yang, Robert Doherty, Andrea Franson, Allison R. Hanaford, Charles G. Eberhart, Eric H. Raabe, Brent A. Orr, Robert J. Wechsler‐Reya, Brandon Chen, Costas A. Lyssiotis, Yatrik M. Shah, Sophia Y. Lunt, Ruma Banerjee, Alexander R. Judkins, John R. Prensner, Carl Koschmann, Sebastian M. Waszak, Deepak Nagrath, Marcos Simões-Costa, Paul A. Northcott, Sriram Venneti

2025Cancer Cell20 citationsDOIOpen Access PDF

Topics & Concepts

Isocitrate dehydrogenaseGroup (periodic table)IDH1MedulloblastomaBiologyDehydrogenaseCancer researchMolecular biologyBiochemistryChemistryEnzymeMutationGeneOrganic chemistryGlioma Diagnosis and Treatmentinterferon and immune responsesCancer-related Molecular Pathways